140 related articles for article (PubMed ID: 24938936)
1. Bedoradrine for treating asthma and chronic obstructive pulmonary disease.
Antoniu S
Expert Opin Investig Drugs; 2014 Aug; 23(8):1149-56. PubMed ID: 24938936
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bedoradrine sulfate (MN-221), a novel, highly selective beta2-adrenergic receptor agonist for the treatment of asthma via intravenous infusion.
Matsuda K; Makhay M; Johnson K; Iwaki Y
J Asthma; 2012 Dec; 49(10):1071-8. PubMed ID: 23094708
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a new intravenous β2-adrenergic agonist (bedoradrine, MN-221) for patients with an acute exacerbation of asthma.
House SL; Matsuda K; O'Brien G; Makhay M; Iwaki Y; Ferguson I; Lovato LM; Lewis LM
Respir Med; 2015 Oct; 109(10):1268-73. PubMed ID: 26324315
[TBL] [Abstract][Full Text] [Related]
4. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.
Patel M; Thomson NC
Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221
[TBL] [Abstract][Full Text] [Related]
5. Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease.
Malerba M; Radaeli A; Montuschi P; Babu KS; Morjaria JB
Expert Opin Investig Drugs; 2017 Mar; 26(3):319-329. PubMed ID: 28117615
[TBL] [Abstract][Full Text] [Related]
6. β2-agonist therapy in lung disease.
Cazzola M; Page CP; Rogliani P; Matera MG
Am J Respir Crit Care Med; 2013 Apr; 187(7):690-6. PubMed ID: 23348973
[TBL] [Abstract][Full Text] [Related]
7. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
Ohar JA; Donohue JF
Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
[TBL] [Abstract][Full Text] [Related]
8. Combination of fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease.
Bollmeier SG; Prosser TR
Ann Pharmacother; 2014 Feb; 48(2):250-7. PubMed ID: 24259654
[TBL] [Abstract][Full Text] [Related]
9. Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
Beeh KM; Beier J
Adv Ther; 2009 Jul; 26(7):691-9. PubMed ID: 19609496
[TBL] [Abstract][Full Text] [Related]
10. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
[TBL] [Abstract][Full Text] [Related]
11. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
Rabe KF
Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
[TBL] [Abstract][Full Text] [Related]
12. Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.
Kerwin EM; Williams J
Ther Adv Respir Dis; 2013 Feb; 7(1):25-37. PubMed ID: 23296242
[TBL] [Abstract][Full Text] [Related]
13. Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.
Hagedorn C; Kässner F; Banik N; Ntampakas P; Fielder K
Respir Med; 2013 Apr; 107(4):542-9. PubMed ID: 23337300
[TBL] [Abstract][Full Text] [Related]
14. Update on ultra-long-acting β agonists in chronic obstructive pulmonary disease.
Zafar MA; Droege C; Foertsch M; Panos RJ
Expert Opin Investig Drugs; 2014 Dec; 23(12):1687-701. PubMed ID: 25139313
[TBL] [Abstract][Full Text] [Related]
15. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
[TBL] [Abstract][Full Text] [Related]
16. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
Dalonzo GE
J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic agents in asthma and COPD.
Gross NJ
Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology and therapeutics of bronchodilators.
Cazzola M; Page CP; Calzetta L; Matera MG
Pharmacol Rev; 2012 Jul; 64(3):450-504. PubMed ID: 22611179
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of inhaled tiotropium in asthma, uncontrolled with standard combination therapy.
Antoniu SA; Antohe I
Expert Opin Pharmacother; 2013 May; 14(7):967-9. PubMed ID: 23514606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
